Jilin Xidian Pharmaceutical Technology Development Co., Ltd
Initial public offering and listing on GEM
Announcement of online lottery results
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
hot tip
Please pay attention to the payment link of this offering and fulfill the payment obligation on February 16, 2022 (T + 2):
1. According to the announcement of China Securities Development Co., Ltd. on February 16, 2022, the investors of Jilin Province Science and Technology Co., Ltd. shall be deemed to have given up the obligation of issuing new shares in full amount after the subscription of new shares on the Internet is signed by China Securities Development Co., Ltd. according to the announcement of China Securities Development Co., Ltd. on February 16, 2022, The resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The investor's fund transfer shall comply with the relevant provisions of the securities company where the investor is located.
Haitong Securities Company Limited(600837) (hereinafter referred to as " Haitong Securities Company Limited(600837) " or "sponsor (lead underwriter)") serves as the sponsor (lead underwriter) of this offering. The shares that online investors give up to subscribe for shall be underwritten by the sponsor (lead underwriter).
2. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
3. If online investors fail to pay in full after winning the lottery for three times in a row within 12 months, they shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant's latest declaration of abandonment of subscription. 4. Once this announcement is published, it shall be deemed to have served the notice of allocated payment to the online investors who have participated in the online subscription and won the lot.
According to the "Jilin West Point Pharmaceutical Technology Development Co., Ltd. initial public offering of shares and listed on the gem"
Announcement on listing and issuance, the issuer and the sponsor (lead underwriter) presided over the signing and number shaking ceremony of the initial public offering of Jilin Xidian Pharmaceutical Technology Development Co., Ltd. in Room 308, Shenye center, No. 5045, Shennan East Road, Luohu District, Shenzhen on the morning of February 15, 2022 (t + 1). The lottery ceremony was conducted and notarized under the supervision of the representative of Shenzhen Luohu notary office in accordance with the principles of openness, fairness and impartiality. The winning results are announced as follows:
The last digit of the winning lot number is 9214, the last "5" digit is 444856448584485044852448586267, and the last "6" digit is 24336144336164336184361043361941733191733441733691733
Last "7" digit 7274022 last "9" digit 052088898
If the mantissa of the subscription allotment number held by investors participating in the online pricing issuance and subscription of shares of Jilin West Point Pharmaceutical Technology Development Co., Ltd. is the same as the above number, it is the winning number. There are 19595 winning numbers in total, and each winning number can only subscribe for 500 A-Shares of Jilin West Point Pharmaceutical Technology Development Co., Ltd.
Issuer: sponsor (lead underwriter) of Jilin West Point Pharmaceutical Technology Development Co., Ltd.: Haitong Securities Company Limited(600837) February 16, 2022 (no text on this page) (seal page of announcement on the results of initial public offering and online lottery of Jilin Xidian Pharmaceutical Technology Development Co., Ltd. listed on GEM)
Issuer: Jilin West Point pharmaceutical science and Technology Development Co., Ltd. (this page has no text, which is the seal page of the announcement on the results of Jilin West Point pharmaceutical science and Technology Development Co., Ltd. initial public offering and online lottery for listing on the GEM)
Sponsor (lead underwriter): Haitong Securities Company Limited(600837) mm / DD / yy
